Matthew Hewitt

Stock Analyst at Craig-Hallum

(1.82)
# 2,067
Out of 4,667 analysts
1
Total ratings
100%
Success rate
42.57%
Average return

Stocks Rated by Matthew Hewitt

Lifecore Biomedical
Sep 5, 2024
Initiates: Buy
Price Target: $8
Current: $7.48
Upside: +6.95%